Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nadejda Mudie"'
Publikováno v:
Transplant International
Summary Ganciclovir (GCV) inhibits spermatogenesis in preclinical studies but long‐term effects on fertility in renal transplant patients are unknown. In a prospective, multicenter, open‐label, nonrandomized study, male patients were assigned to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0db565d6b23ce9d4f15b277f11643227
https://doi.org/10.1111/tri.13558
https://doi.org/10.1111/tri.13558
Publikováno v:
Journal of cardiovascular pharmacology. 65(4)
Inclacumab is a novel monoclonal antibody directed against P-selectin in development for the prevention and treatment of atherosclerotic cardiovascular diseases. It is likely to be used concomitantly with heparin in patients undergoing percutaneous c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dea8664f89227ed3cbb3c1ff6e890ce9
https://pubmed.ncbi.nlm.nih.gov/25602360
https://pubmed.ncbi.nlm.nih.gov/25602360
Autor:
A. Michael Lincoff, Markolf Hanefeld, Matthias Herz, Sylvie Meyer Reigner, Nadejda Mudie, Giancarlo Viberti, Klas Malmberg, Luis M. Ruilope, Teresa Urbanowska
Publikováno v:
Atherosclerosis. 231:e3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c800b6f5a8153c38dab32eb000ccc6a
https://doi.org/10.1016/j.atherosclerosis.2013.07.015
https://doi.org/10.1016/j.atherosclerosis.2013.07.015
Autor:
Stephen J. Nicholls, Nadejda Mudie, A. Michael Lincoff, Klas Malmberg, Matthias Herz, Markolf Hanefeld
Publikováno v:
Heart. 99:A248.1-A248
Objectives Dyslipidemia, characterised by increased ratios of triglycerides (TG) and total cholesterol (TC) to high-density lipoprotein cholesterol (HDL-C), is a cardiovascular (CV) risk factor in patients with type 2 diabetes (T2D). 1 In addition to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abbe43b88e163695ae0603ba7bd377d3
https://doi.org/10.1136/heartjnl-2013-304613.699
https://doi.org/10.1136/heartjnl-2013-304613.699
Autor:
Giancarlo Viberti, Luis Ruilope, Klas Malmberg, A. Lincoff, Markolf Hanefeld, Nadejda Mudie, Teresa Urbanowska
Publikováno v:
Journal of the American College of Cardiology. 61:E1173
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40eea79cae94d5237a16726b2b35b093
https://doi.org/10.1016/s0735-1097(13)61173-0
https://doi.org/10.1016/s0735-1097(13)61173-0
Autor:
Beatrice Malmer, Maria Feychting, Stefan Lönn, Sara Lindström, Anders Ahlbom, Helle Collatz-Christensen, Christoffer Johansen, Anne Kiuru, Nadejda Mudie, Minouk Schoemaker, Anthony Swerdlow, Roger Henriksson
Publikováno v:
Journal of Neuro-Oncology; May2007, Vol. 82 Issue 3, p229-237, 9p
Autor:
Sarayut Lucien Geater, Saulius Cicenas, Fan Xia, Petar Petrov, Yevgeniy Hotko, Gregory Hooper, Yi-Long Wu, Nadejda Mudie
Publikováno v:
Lung Cancer. :30-37
Objective The phase III IUNO trial assessed the benefit of maintenance erlotinib versus erlotinib at progression in advanced/metastatic non-small-cell lung cancer (NSCLC) that had not progressed following four cycles of platinum-based chemotherapy. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b61c0b147d4dad4bc268ec61ab960c2
Autor:
Markolf Hanefeld, Klas Malmberg, A. Michael Lincoff, Nadejda Mudie, Sylvie Meyer-Reigner, Dominika Wieczorek Kirk, Luis M. Ruilope, Giancarlo Viberti, Matthias Herz
Publikováno v:
BMC Nephrology
Background Type 2 diabetes is a major risk factor for chronic kidney disease, which substantially increases the risk of cardiovascular disease mortality. This Phase IIb safety study (AleNephro) in patients with stage 3 chronic kidney disease and type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140b5ac3c75faa05d86c47379cdfb5d8